Key Points:
1.The Polish Senate unanimously passed a ban on flavored and heated tobacco products, which will now await final approval from the President's office.
2.Manufacturers and retailers will have a 9-month period to make adjustments, as the bill aims to implement EU directives.
3.Another e-cigarette restriction bill is currently being debated in the Polish parliament.
According to Dlahandlu, on March 13th, the Polish Senate unanimously passed a amendment to the "Law on Protecting Health from the Effects of Tobacco and Tobacco Products.
The new law prohibits the sale of flavored heated tobacco products, and manufacturers and retailers will have 9 months to comply with this new regulatory requirement. This legislation aims to implement relevant directives from the European Union, with all member states expected to enforce it by October 23, 2023.
As early as February 21st, the Polish Parliament had already passed the bill amendment. The bill has now been submitted to the President's Office awaiting final approval.
In addition, the Polish parliament is also in the process of revising a separate bill concerning e-cigarettes, which aims to restrict the sale of e-cigarettes. In early February, the Health Committee of the Polish parliament decided to postpone the detailed review of this bill until after April 28th, as it requires submitting the proposal for consideration to the European Commission.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
